Hook & thesis
Selective Insurance (SIGI) has taken clear steps back toward underwriting sanity. The company reported a combined ratio of 96.8% in Q3, down meaningfully versus prior quarters, and net investment income jumped roughly 16% year-over-year, which helped EPS comfortably beat on 10/22/2026. Those two forces - improving underwriting and stronger investment income - are why I think a selective long makes sense today.
That said, the business is not yet back to its best: net premiums written and earned are still negative year-over-year, and catastrophe activity plus elevated expense pressures keep volatility high. My trade idea is therefore conditional and sized for a mid- to longer-term horizon: buy on strength around the current level with a firm stop under the recent swing low, target modest upside to reflect valuation and execution risk, and re-evaluate on subsequent premium trends and reserve development.
What Selective does and why the market should care
Selective is a property & casualty insurer operating Standard Commercial Lines, Standard Personal Lines, E&S (excess & surplus) Lines and Investments. The company serves commercial customers (including non-profits and local governments), personal lines policyholders and customers who need non-standard coverage. Insurance is a capital-intensive, underwriting-driven business: profits hinge on keeping the combined ratio below 100% while growing premiums without taking on disproportionate catastrophe or reserve risk.
The market cares because Small shifts in the combined ratio and investment income flow directly to underwriting profitability and to EPS. In the latest quarter Selective demonstrated both levers working in its favor: a 96.8% combined ratio and a roughly 15.7-16% lift in net investment income (~$160.5 million), which helped deliver EPS of $2.37 and a sizeable beat versus consensus on 10/22/2026.
Hard numbers that matter
- Q3 revenue: ~$1.35 billion (down ~0.5% YoY) and EPS of $2.37, topping estimates by ~24%.
- Combined ratio: 96.8% in Q3, below the 100% consensus expectation and improved from the prior-year period.
- Net investment income: ~$160.5 million, up about 15.7% YoY.
- Premium trends: net premiums written declined (news points to a ~7% decline at one point; net premiums earned down ~2% YoY), highlighting weak top-line premium momentum.
- Valuation snapshot: market cap roughly $6.10 billion; trailing P/E ~12; P/B ~1.8; enterprise value ~$6.89 billion; EV/EBITDA ~9.4; free cash flow roughly $1.139 billion (P/FCF ~5.3 implied).
Valuation framing
Selective is trading with a modestly conservative multiple: a stated P/E around 12 and P/B near 1.8. Those are not nosebleed multiples for an insurer showing improving underlying margin metrics. The company generated strong free cash flow on the dataset (~$1.14 billion), which, against a market cap near $6.1 billion, suggests an attractive FCF yield (P/FCF in the low single-digits per the dataset). That said, the multiple compression that occurred earlier in the year (52-week low $72.78) baked in fears around underwriting and premium growth. The recent rebound toward the 52-week high ($105.65) reflects better Q3 execution and analysts nudging up estimates (consensus EPS for fiscal 2026 moved toward the low $8s in recent revisions).
Qualitatively: investors should treat the valuation as reasonable if underwriting improvement proves durable and premium declines stabilize. If premiums continue to slide or reserve deterioration emerges, the current multiple will quickly look expensive.
Trade plan (actionable)
My recommendation: a selective long with clear risk controls.
| Entry | Stop | Target | Trade direction | Horizon |
|---|---|---|---|---|
| $103.36 | $97.00 | $115.00 | Long | Long term (180 trading days) |
Rationale: entry at the current price ($103.36) captures the recent improvement in the combined ratio and continued tailwind from higher investment income while leaving room for downside should premium trends disappoint. The stop at $97 is just below a meaningful short-term moving average cluster (10-/21-day EMAs near the low $100s and the 50-day nearer the low $90s), giving the trade room for normal volatility but cutting losses if the stock breaks materially under short-term support. The $115 target is conservative - it reflects roughly a mid-single-digit percentage premium to current levels and is consistent with a ~13-14x multiple on forward EPS if Selective continues to deliver improved underwriting and stable premiums. Expect to hold the position up to 180 trading days while monitoring premium and reserve trends closely.
Catalysts to watch
- Reserve development and calendar-year catastrophe impact: any confirmation that reserve releases are stable and catastrophe losses normalize would validate the improved combined ratio trajectory.
- Premium growth stabilization: sequential improvement in net premiums written/earned would materially change the earnings trajectory and help justify a higher multiple.
- Investment income momentum: continued gains in net investment income (benefiting from higher yields or portfolio shifts) support EPS even if underwriting recovers slowly.
- Analyst estimate revisions: further upward revisions to FY2026 and FY2027 EPS from multiple analysts.
- Dividend policy / buyback updates: any management signal around capital return would support the income-case and lower perceived risk.
Risks and counterarguments
The trade is constructive but not without material risks. Below are the principal ones to consider:
- Premium contraction continues or accelerates. Net premiums written and earned were down year-over-year; if this trend extends, top-line pressure will offset underwriting gains and cap EPS upside. Selective's results still depend heavily on premium growth to expand scale and margins.
- Catastrophe volatility. Insurers remain exposed to large catastrophe events. A single material event could swing the combined ratio back above 100% and force reserve strengthening. The most recent quarter still contained catastrophe losses.
- Expense creep and rate adequacy. Rising expense ratios or inadequate rate increases in certain book segments could compress margins even with loss ratio improvements.
- Reserve development surprises. Prior-period reserve strengthening is always a latent risk; adverse reserve development would show up as an earnings headwind and could spook the market.
- Technical and sentiment risk. The stock's RSI is above 70, implying near-term overbought conditions. Short interest and active short-volume days can magnify intraday moves and create whipsaw risk for a long position.
Counterargument: A skeptical investor would argue the EPS beat was driven more by investment income than durable underwriting improvement. If investment yields reverse or losses reaccelerate, the EPS beat could prove fleeting and leave the valuation rich versus fundamentals. That is why the trade uses a tight stop and a relatively modest target - it buys the progress while respecting the fragility of premium trends.
What would change my view
I would become materially more bullish if we see two developments: (1) at least two consecutive quarters of stable-to-positive net premiums written/earned, showing pricing and new business momentum; and (2) continued combined-ratio improvement with reserve releases held steady or improving. Conversely, a meaningful deterioration in reserve metrics, another quarter with combined ratio above 100% or a renewed drop in premium volumes would make me exit and re-assess.
Bottom line
Selective Insurance is showing credible signs of underwriting improvement and benefits from stronger investment income. The stock's valuation metrics - low-teens P/E, P/B ~1.8 and attractive P/FCF - make a selective long reasonable for patient investors. However, premium growth remains the key missing piece to a full recovery thesis. The recommended trade is therefore a measured long: enter at $103.36, stop at $97.00, target $115.00, and plan to hold for up to 180 trading days while watching premium trends, catastrophe results and reserve developments closely.
Key monitoring checklist (actionable)
- Next two quarterly premium trends (net premiums written/earned).
- Reserve development detail and calendar-year catastrophe commentary.
- Investment income run-rate and any changes to the investment portfolio strategy.
- Dividend or capital return changes announced ahead of ex-dividend dates (11/16/2026 record/ex-div dates are on the calendar).